The Ontario Medical Association (OMA) and Primary Care Collaborative have called for $37.5 million in immediate funding, as well as $75 million annually for 10 years, to help primary care providers treat patients with depression, anxiety, and addiction. The recommendation is part of a four-point plan to strengthen mental health and […]
Read More
A continuación un resumen de algunos temas destacados en México del 7 al 13 de octubre de 2022. Actualización de lineamientos contra la COVID-19 en lugares de trabajo El 10 de octubre el Comité de Nueva Normalidad, conformado por las secretarías de Salud, Economía, Trabajo y Previsión Social (STPS), y […]
Read More
La decisión de no vacunarse contra la COVID-19 por ya haber pasado la enfermedad y confiar en la inmunidad adquirida de forma natural es una mala elección, al menos antes de que la variante ómicron fuese la dominante. Esta es la principal conclusión de un estudio liderado por investigadores del […]
Read More
More than 2 years into the coronavirus disease 2019 (Covid-19) pandemic, the global population carries heterogeneous immune histories derived from various exposures to infection, viral variants, and vaccination.1 Evidence at the level of binding and neutralizing antibodies and B-cell and T-cell immunity suggests that a history of infection with severe acute […]
Read More
The ongoing monkeypox outbreak was recently declared to be a Public Health Emergency of International Concern by the World Health Organization.1 Young children are at risk for severe disease; therefore, early recognition and prompt treatment are important.2 We report a case of perinatally acquired monkeypox virus infection and adenovirus coinfection in […]
Read More
Créditos: Comité científico Covid
Read More
Question Among individuals who had symptomatic SARS-CoV-2 infection in 2020 and 2021, what proportion experienced common self-reported Long COVID symptom clusters 3 months after initial infection? Findings This observational analysis involved bayesian meta-regression and pooling of 54 studies and 2 medical record databases with data for 1.2 million individuals (from 22 countries) […]
Read More
A rebound of COVID-19 symptoms in some patients after taking Pfizer’s antiviral Paxlovid may be related to a robust immune response rather than a weak one, U.S. government researchers reported on Thursday. They concluded that taking a longer course of the drug – beyond the recommended five days – was […]
Read More
A potentially fatal strain of flu currently in circulation worldwide could be more of a threat to public health than COVID this winter, a senior government health adviser has warned. Dr Susan Hopkins, chief medical adviser at UK Health Security Agency (UKHSA) warned that COVID will still present a major challenge for […]
Read More
Puntos clave Algunos viajeros que han pasado tiempo en México se han infectado con Salmonella Newport multirresistente (MDR, por sus siglas en inglés). La Salmonella MDR ha desarrollado la capacidad de vencer a los medicamentos diseñados para eliminarla. Las infecciones por Salmonella MDR pueden ser difíciles de tratar. Los médicos deben seguir las directrices de los CDC […]
Read More